[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.15616/BSL.2020.26.3.127

A Review of Recent Trend of COVID-19 Infection and Correlation with Pulmonary Function

Kim, Min Woo (Department of Surgery, Yonsei University College of Medicine)

Abstract

Coronavirus is generally known to cause minor respiratory diseases in animals and humans. However, some coronavirus genus is reported to cause animal-to-human interspecies infection. Since the end of 2019, a new type of coronavirus (COVID-19) infection is spreading rapidly throughout the world, leading to the declaration of the pandemic by the World Health Organization (WHO). Despite various clinical studies to counter COVID-19 infection, the total confirmed cases and death rates are still accumulating. To break down this new threat, we should pay attention to newly revealed information based on scientific facts. In this review, we introduced the clinical characteristics, diagnostic methods, and treatment of patients infected with COVID-19. Moreover, we highlighted the correlation between COVID-19 severity and patients with underlying diseases. Potential risks associated with COVID-19 can be differed depending on the condition of patients and can cause pulmonary complications. Therefore, lung capacity exams are expected to help predict the progression of the disease along with previously established detection methods such as molecular diagnostics and immunoassay. Although physiological research hasn't yet been emphasized to evaluate COVID-19 infection, this review is expected to be valuable to give new inspiration to deal with COVID-19 which might strike again in the future.

Keywords

COVID-19; SARS-CoV-2; Pulmonary function; Clinical characteristics;

Citations & Related Records

Reference

1	Cucinotta D, Vanelli M. Who declares COVID-19 a pandemic. Acta Biomed. 2020. 91: 157-160.
2	Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019. 17: 181-192. DOI
3	Daccord C, Touilloux B, Von Garnier C. Asthma and copd management during the COVID-19 pandemic. Rev Med Suisse. 2020. 16: 933-938.
4	Ganji A, Farahani I, Khansarinejad B, Ghazavi A, Mosayebi G. Increased expression of CD8 marker on t-cells in COVID-19 patients. Blood Cells Mol Dis. 2020. 83: 102437. DOI
5	Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: Ards or not? Crit Care. 2020. 24: 154. DOI
6	Geier MR, Geier DA. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Med Hypotheses. 2020. 140: 109760. DOI
7	Ciaglia E, Vecchione C, Puca AA. COVID-19 infection and circulating ACE2 levels: Protective role in women and children. Front Pediatr. 2020. 8: 206. DOI
8	Giwa AL, Desai A, Duca A. Novel 2019 coronavirus SARSCoV- 2 (COVID-19): An updated overview for emergency clinicians. Emerg Med Pract. 2020. 22: 1-28.
9	Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 382: 1708-1720. DOI
10	Guo L, Ren L, Yang S, Xiao M, Chang, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang Q, Xu S, Zhu H, Xu Y, Jin Q, Sharma L, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020. 10.1093/cid/ciaa310.
11	Rothlin RP, Vetulli HM, Duarte M, Pelorosso FG. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19. Drug Dev Res. 2020. 10.1002/ddr.21679.
12	Saverino D. COVID-19: Are T lymphocytes simply watching? Panminerva Med. 2020. 10.23736/S0031-0808.20.03934-8.
13	Schrank CL, Minbiole KPC, Wuest WM. Are quaternary ammonium compounds, the workhorse disinfectants, effective against severe acute respiratory syndrome-coronavirus-2? ACS Infect Dis. 2020. 10.1021/acsinfecdis.0c00265.
14	Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: Ct and clinical features. Korean J Radiol. 2020. 21: 537-540. DOI
15	Sun L, Liu G, Song F, Shi N, Liu F, Li S, Li P, Zhang W, Jiang X, Zhang Y, Sun L, Chen X, Shi Y. Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19. J Clin Virol. 2020. 10.1016/j.jcv.2020.-104431: 104431.
16	Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, Park JS, Kim GJ, Sung H, Roh KH, Kim JS, Kim HS, Lee ST, Seong MW, Ryoo N, Lee H, Kwon KC, Yoo CK. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020. 40: 351-360. DOI
17	Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 395: 497-506. DOI
18	Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020. 181: 914-921 e910. DOI
19	Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020. 581: 215-220. DOI
20	Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR, Sin DD. ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur Respir J. 2020. 55: 2000688. DOI
21	Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016. 3: 237-261. DOI
22	Vashist SK. In vitro diagnostic assays for COVID-19: Recent advances and emerging trends. Diagnostics (Basel). 2020. 10.
23	Vijgen L, Moes E, Keyaerts E, Li S, Van Ranst M. A pancoronavirus RT-PCR assay for detection of all known coronaviruses. Methods Mol Biol. 2008. 454: 3-12. DOI
24	Vittori A, Lerman J, Cascella M, Gomez-Morad AD, Marchetti G, Marinangeli F, Picardo SG. COVID-19 pandemic ards survivors: Pain after the storm? Anesth Analg. 2020. 10.1213/ANE.0000000000004914.
25	Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020. 83: 217-220. DOI
26	Xie X, Chen J, Wang X, Zhang F, Liu Y. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. 2006. 78: 2166-2171. DOI
27	Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical 2019-nCoV pneumonia: Relationship to negative RTPCR testing. Radiology. 2020. 10.1148/radiol.2020200343:200343.
28	Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y, Wang J, Huang B, Lin Y, Yang J, Cai W, Wang X, Cheng J, Chen Z, Sun K, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020. 10.1002/jmv.25727.
29	Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020. 21: 335-337. DOI
30	Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020. 8: 420-422. DOI
31	Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020. 39: 101166. DOI
32	Ma Y, Xu QN, Wang FL, Ma XM, Wang XY, Zhang XG, Zhang ZF. Characteristics of asymptomatic patients with SARS-CoV-2 infection in jinan, china. Microbes Infect. 2020. 10.1016/j.micinf.2020.04.011.
33	Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Hlh Across Speciality Collaboration UK. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020. 395: 1033-1034. DOI
34	Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C, Li S, Chen R, Zhong N. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020. 10.1183/13993003.01217-2020: 2001217.
35	Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: What we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020. 42: 505-514. DOI
36	Oh J, Lee JK, Schwarz D, Ratcliffe HL, Markuns JF, Hirschhorn LR. National response to COVID-19 in the Republic of Korea and lessons learned for other countries. Health Syst Reform. 2020. 6: e1753464. DOI
37	Rasmussen SA, Watson AK, Swerdlow DL. Middle east respiratory syndrome (MERS). Microbiol Spectr. 2016. 4: 10.1128/microbiolspec.EI10-0020-2016
38	Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Pandemic (COVID-19). 2020. Published online at OurWorldInData.org.
39	Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, Wolfel R, Hoelscher M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. 382: 970-971. DOI
40	Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020. 10.1056/NEJMoa2015432.
41	Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom J-S, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in korea. J Korean Med Sci. 2020. 35: e149. DOI
42	Ahsan W, Javed S, Bratty MA, Alhazmi HA, Najmi A. Treatment of SARS-CoV-2: How far have we reached? Drug Discov Ther. 2020. 14: 67-72. DOI
43	Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR. Prevalence, severity and mortality associated with copd and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLoS One. 2020. 15: e0233147. DOI
44	Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of covid-19. JAMA. 2020. 10.1001/jama.2020.2565.
45	Barreiro TJ, Perillo I. An approach to interpreting spirometry. Am Fam Physician. 2004. 69: 1107-1114.
46	Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020. 153: 725-733. DOI
47	Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci. 2020. 50: 563-570. DOI
48	Chan-Yeung M, Xu RH. Sars: Epidemiology. Respirology. 2003. 8 Suppl: S9-14. DOI
49	Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, Gong, W, Han JJ. Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation. 2020. 2020030191. Preprints.
50	Choe JY, Kim JW, Kwon HH, Hong HL, Jung CY, Jeon CH, Park EJ, Kim SK. Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019. J Med Virol. 2020. 10.1002/jmv.26060.